April 24, 2026

The Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 Through: BSE Listing portal SCRIP CODE: 500027 SYMBOL: ATUL

The Manager Listing Department National Stock Exchange of India Limited "Exchange Plaza" C – 1, Block G Bandra Kurla Complex, Bandra (East) Mumbai 400 051 Through: NEAPS

Dear Sir,

Sub: Outcome of the Board meeting

Financial results

Pursuant to Regulation 30 and 33(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting the following for the year ended on March 31, 2026:

a) audited standalone and consolidated financial results.
b) auditor's report on standalone financial results.
c) auditor's report on consolidated financial results.

Integrated filling (Financials) pursuant to the SEBI circular no SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, is being done separately in xbrl format in accordance with relevant circulars issued by the stock exchanges.

Further, pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Chapter III, Section III-A, clause (D), sub-clause 19 of the SEBI master circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, we declare and confirm that the auditor's reports on standalone financial results and consolidated financial results are unmodified.

Dividend, book closure and record date

The Board of Directors of the Company proposed dividend of ₹ 30 (Rupees Thirty only) per equity share for the year ended March 31, 2026 which is subject to approval of the members at the ensuing Annual General meeting (AGM) to be held on July 31, 2026.

The Register of Members and Share Transfer Books shall remain closed from July 18, 2026, to July 24, 2026 (both days inclusive) and accordingly the record date for the purpose of ascertaining the eligibility of the members to receive the dividend is July 17, 2026.

After the approval by the members at the AGM, date for payment of dividend will be on or after August 05, 2026.

Reappointment of Director

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee and subject to approval of the members of the Company, the Board of Directors has reappointed Mr Samveg Lalbhai (DIN: 00009278), as a Managing Director of the Company effective December 15, 2026 for a period of five years.

The information required pursuant to provisions of Schedule III of the Regulations is enclosed as Annexure A.

The above were taken on record by the Board of Directors of the Company today at 01:45 pm at their meeting. Please note that the meeting commenced at 10:00 am and is continuing for other routine agenda items.

Please acknowledge the receipt and inform the members of the exchange.

Thank you,

Yours faithfully,

For Atul Limited

Lalit Patni Company Secretary and Chief Compliance Officer Encl.: as above LALIT PATNI

Atul Ltd

Atul House, G I Patel Marg, Ahmedabad 380 014, Gujarat, India [email protected] I www.atul.co.in (+91 79) 26461294 I 3706 CIN:L99999GJ1975PLC002859

Part I: Standalone financial results for the quarter I year ended on March 31, 2026

			Quarter ended on		Year ended on
No.	Particulars	March 31, 2026	December 31, 2025	March 31, 2025	March 31, 2026	March 31, 2025
		Unaudited	Unaudited	Unaudited	Audited	Audited
01.	INCOME
	a) Revenue from operations	1.497.93	1,351.56	1,314.79	5,563.57	5,074.69
	b) Other income	74.96	36.45	54.51	198.91	132.99
	Total income	1,572.89	1,388.01	1,369.30	5,762.48	5,207.68
02.	EXPENSES
	a) Cost of materials consumed	804.79	682.60	677.82	3,007.16	2.683.74
	b) Purchases of stock-in-trade	23.98	19.78	14.59	79.39	57.00
	c) Changes in inventories of finished goods, work-in-progress and stock-in-trade	3.39	32.61	5.21	(20.40)	(118.67)
	d) Power, fuel and water	144.11	131.45 - -	137.96	556.06	577.21
	e) Employee benefit expenses (refer Note 4)	80.20	134.74	93.36	406.64	364.29
	Finance costs f)	0.87	0.90	1.54	3.59	6.31
	g) Depreciation and amortisation expenses	52.33	53.06	55.26	215.96	213.04
	h) Other expenses	214.48	177.99	218.07	754.11	801.43
	Total expenses	1,324.15	1,233.13	1,203.81	5,002.51	4,584.35
03.	Profit before tax -	248.74	154.88	165.49	759.97	623.33
04.	~~S1'lNS & Tax expense ~ J'~
	ff ~ a) Current tax 6,(,,	54.35	33.33	37.03	169.79	149.68
-	~ MUMBAI r;; b) Deferred tax *	4.79	0.40	6.65	9.38	21.21
	* Tax expense for the year ~ ~	59.14	33.73	43.68	179.17	170.89
	~fli'ED AC~~'i'- Excess provision of tax relating to earlier years -	(14.24)	-	(3.88)	(14.24)	(3.84)
	Total tax expense	44.90	33.73	39.80	164.93	167.05
05.	Profit for the period	203.84	121.15	125.69	595.04	456.28

Part I: Standalone financial results for the quarter I year ended on March 31, 2026

			Quarter ended on		Year ended on
No.	Particulars	March 31, 2026	December 31, 2025	March 31, 2025	March 31, 2026	March 31, 2025
		Unaudited	Unaudited	Unaudited	Audited	Audited
	06. Other comprehensive income
	a) Items that will not be reclassified to profit I loss
	Fair value of equity instruments through other comprehensive income i)	(68.95)	(24.66)	(225.62)	(8.68)	67.83
	ii) Remeasurement gain I (loss) on defined benefit plans	3.43	- 1.78	(2.14)	6.04	(0.26)
	iii) Income tax related to items above	8.65	3.10	32.10	(l.27)	(16.15)
	b) Items that will be reclassified to profit I loss
	Effective portion of gain I (loss) on cash flow hedges i)	-	0.19	0.76	-	(0.29)
	ii) Income tax related to items above	-	(0.05)	(0.19)	-	0.07
	Other comprehensive income, net of tax	(56.87)	(19.64)	(195.09)	(3.91)	51.20
	07. Total comprehensive income for the period	146.97	101.51	(69.40)	591.13	507.48
	08. Paid-up equity share capital (face value f 10 per share)	29.44	29.44	29.44	29.44	29.44
	09. Other equity				6,026.46	5,508.65
	10. Earnings per equity share off 10 each (not annualised, excluding year end)
	Basic earnings (~)	69.24	41.15	42.69	202.11	154.98
	Diluted earnings ~)	69.24	41.15	42.69	202.11	154.98

Part II: Standalone Balance Sheet

		As at
No.	Particulars	March 31,	March 31, 2025
		2026
		Audited	Audited
A	ASSETS	-
1	Non-current assets Property. plant and equipment	1,640.07	1,737.93
	a)	80.81	91.36
	-- Capital work-in-progress b)		3.22
	Investment property c)	3.22
	Intangible assets d)	0.25	0.78
	Financial assets e)	1.217.36	1,201.79
	Investments in subsidiary companies and joint venture company i) ii) Other investments	860.93
		19.00	869.62 - 8.00
	iii) Loans	16.90	17.49
	iv) Other financial assets Other non-current assets	24.36	. 31.36
	f)	3,862.90	--- 3,961.55
	Total non-current assets -
2	-- -- Current asse~ Inventories	727.22	u 655.36
	a) Financial assets
	b) --- Investments	1,366.12	757.80
	i) Trade receivables	1.175.58	1,027.22
	ii) iii) Cash and cash equivalents	17.75	1.50
	-- Bank balances other than (iii) above iv)	2.79	2.77
	Loans	-- 34.72	--- - 33.22
	v) - vi) Other financial assets	22.95	18.03
	Other current assets	86.66	-- 93.81
	c) Total current assets	3,433.79	-- 2,589.71
	Total assets	7,296.69	6,551.26
B	- EQUITY AND LIABILITIES
	Equity
	Equity share capital a)	29.46	29.46
	Other equity b)	6,026.46	5,508.65
	Total equity	6,055.92	5,538.11
	Liabilities
1	Non-current liabilities
	a) Other financial liabilities	3.84	3.70
	- Provisions b)	--- 28.49	33.30
	Deferred tax liabilities (net) c)	--- 173.32	164.19
	Total non-current liabilities	205.65	201.19
2	-- Current liabilities
	Financial liabilities a)
	Borrowings i)	6.50	8.06
	Trade payables ii)
	Total outstanding dues of
	a) Micro-enterprises and small enterprises	79.38	33.66
	b) Creditors other than micro-enterprises and small enterprises	-- 744.65	576.07 -
	iii) Other financial liabilities	126.89	-- 136.71
-	Contract liabilities b)	-- 36.38	27.14
	Other current liabilities - c)	-- -- 11.07	10.61
	Provisions d) ~~-:,\<.INS& &	16.62	15.40
	Current tax liabilities (net) e)	13.63	4.31
	;	-	811.96 - 1,013.15
			6,551.26
	tg -- g --- ~ Total current liabilities I g MUMBAI ~ Total liabilities * .,,_\$ '?) Total equity and liabilities	1,035.12 1,240.77 7,296.69

Part Ill: Standalone Statement of Cash Flows

			(fer)
		For the year ended on
	Particulars	March 31,	March 31,
		2026	2025
		-- Audited	Audited
A	CASH FLOW FROM OPERATING ACTIVITIES
	Profit before tax	759.97	623.33
	Adjustments for:
	Depreciation and amortisation expenses Finance costs	215.96 3.59	213.04 6.31
	Loss on disposal of property, plant and equipment (net)	1.70	3.77
	Insurance claim	-	(24.86)
	Unrealised exchange rate difference (net)	(18.05)	3.32
	Bad debts and irrecoverable balances written off	3.24	3.70
	Allowance for doubtful debts I (written back)	(0.44)	2.62
	Dividend income	(56.65)	(32.79)
	Interest income	(23.32)	(12.69)
	___ Liabilities no long~ required written_b_a_ck _	(0.83)	(0.68)
	Gain on disposal of current investments measured at FVTPL (net)	(65.87)	(35.02)
	Operating profit before change in operating assets and liabilities	819.30	-- 750.05
	Adjustments for:
	(Increase) I Decrease in inventories	(71.86)	(92.16)
	(Increase) I Decrease in non-current and current assets	(121.14)	(164.68)
	Increase I (Decrease) in non-current and current liabilities	219.85	75.23
	__ Cash generated from operations	846.15	-- 568.43
	Income tax paid (net of refund)	Q 30.03)	(141.14)
	Net cash flow from operating activities A	-- 716.12	427.29
B	CASH FLOW FROM INVESTING ACTIVITIES
	Payments towards property, plant and equipment (including capital advances and CWIP)	(129.16)	(190.81)
	Proceeds from disposal of property, plant and equipment	-- 3.05	1.46
	Proceeds from insurance claim	-	22.89
	Redemption of bonds measured at FVTPL	42.40	62.84
	---- Purchase of current investments measured at FVTPL (net)	(583.26)	(275.10)
	Purchase of preference share of subsidiary companies measured at cost	-	(14.50)
	Purchase of equity instruments of subsidiary companies measured at cost	(15.57)	(33.92)
	Repayments of loans given	-- 4.53	35.02
	Disbursements of loans	(15.00)	(2.18)
	Investment in bank deposits (net)	(0.48)	(7.91)
	Interest received	-- 18.17	4.13
	Dividend received from subsidiary companies	-- 22.47	15.10 -
	Dividend received from joint venture company	11.68	8.76
	--- Dividend received from others	19.99	7.73
	Net cash used in investing activities 8	(621.18)	(366.49)
C	CASH FLOW FROM FINANCING ACTIVITIES	-
	Repayments of short-term borrowings (net)	(1.56)	(2.45)
	Interest paid	(3.53)	(6.31)
	Dividend on equity shares	(73.60)	(58.88)
	c Net cash used in financing activities	(78.69)	(67.64)
	Net increase I (decrease) in cash and cash equivalents A+B+C	16.25	(6.84)
	Cash and cash equivalents at the beginning of the tear	-- 1.50	8.34
	Cash and cash equivalents at the end of the year	17.75	1.50

Standalone financial results for the quarter I year ended on March 31, 2026

Notes:

1. These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time.
1. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on April 23, 2026 and approved by the Board of Directors in its meeting held on April 2.4, 2026. The Statutory Auditors have expressed an unmodified audit opinion.
1. The Company publishes the standalone financial results along with the consolidated financial results. In accordance with the Ind AS 108, 'Operating Segments', the Company has disclosed the segment information in the consolidated financial results and therefore no separate disclosure on segment information is given in the standalone financial results for the quarter I year ended on March 31, 2026.
1. On November 21, 2025, the Government of India notified four Labour Codes. effective immediately, replacing the then existing 29 labour laws. In accordance with Ind AS 19 Employee benefits, changes to employee benefit plans arising from legislative amendments are treated as plan amendments. requiring immediate recognition of changes in the past service cost in the standalone financial results. This approach is consistent with the guidance issued by the Institute of Chartered Accountants of India. The Company had assessed the impact of these changes and provided an amount of~ 36.61 er and recognised the same for the quarter and nine months ended on December 31, 2025, as employee benefit expenses. Consequent to the employee compensation restructuring and on actuarial valuation, the said liability is now determined at~ 12.23 er. The excess provision of~ 24.38 er has been reversed in the results for the quarter and year ended March 31, 2026, as a change in estimate. The Company continues to monitor the finalisation of the Central and State rules and the clarifications that may be issued by the Government on the new labour codes and will recognise the impact of changes in the estimates in that period, as needed.
1. The figures of the last quarter represent the balancing figures between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the respective financial year. There are no material adjustments made in the results for the quarter ended on March 31, 2026, which pertain to earlier periods. These have been subjected to limited review by the Auditors.
1. The Board of Directors has recommended a dividend of~ 30 per share (300%) subject to the approval of the shareholders.

s~· (Sunil Lalbhai) Mumbai (DIN: 00045590)

April 24, 2026 ~ Chairman and Managing Director

@ l.r.lbh11i Ciroup

Atul Ltd

Atul House, G I Patel Marg, Ahmedabad 380 014, Gujarat, India [email protected] I www.atul.co.in (+91 79) 264612941 3706 CIN:L99999GJ1975PLC002859

Part IV: Consolidated financial results for the quarter I year ended on March 31, 2026

						('f cr)
			Quarter ended on		Year ended on
No. I	Particulars	March 31, I 2026	I December 31, 2025	March 31, 2025	March 31, 2026	March 31, 2025
		I Unaudited	Unaudited	Unaudited	Audited	Audited
	01. ,INCOME
	a) Revenue from operations	1,670.07	1,573.62	1.451.64	6,273.54	5.583.35
	b) Other income	89.57	38.59	48.70	202.90	109.03
	Total income	- 1,759.64	1,612.21	1,500.34	6,476.44	5,692.38
	02. IEXPENSES
	a) Cost of materials consumed	889.13	744.15	709.42	3,252.99	2,805.42
	b) Purchases of stock-in-trade	29.20	28.71	24.69	100.16	70.14
	c) Changes in inventories of finished goods, work-in-progress and stock-in-trade	(25.28)	53.37	(3.62)	(46.92)	(129.95)
	d) Power, fuel and water	166.13	148.65	150.08	644.69	652.40
	e) Employee benefit expenses (refer Note 4)	107.70	166.73	118.87	515.57	454.61
	f) Finance costs	4.30	3.70	5.42	17.43	23.98
	g) Depreciation and amortisation expenses	79.29	79.80	81.71	322.13	316.82
	h) Other expenses	222.45	184.95	229.27	776.26	817.77
	Total expenses	1,472.92	1,410.06	1,315.84	5,582.31	5,011.19
	03. Profit before share of net profit I (loss) of associate and joint venture companies and tax	286.72	202.15	184.50	894.13	681.19
	04. Share of net profit I (loss) of assaciate and joint venture companies	1.99	1.33	1.59	6.37	11.30
	05. Profit before tax	288.71	203.48	186.09	900.50	692.49
	06. Tax expense
	a) Current tax	59.42	, 38.35	40.83	185.66	161.61
	b) Deferred tax	. 32.34	1.59	18.68	39.61	35.54
	Tax expense for the year	91.76	39.94	59.51	225.27	197.15
	Excess provision of tax relating to earlier years	(14.17)	-	(3.55)	(14.16)	(3.49)
	Total tax expense	77.59	39.94	55.96	211.11	193.66
	~ 07. !Profit for the period	211.12	163.54	130.13	689.39	498.83
	Attributable to:
	Owners of the Company	I 210.151	160.741	I 126.50	I 677.90	483.93
	Non-controlling interests	0.97	2.80	3.63	11.49	14.90

Part IV: Consolidated financial results for the quarter I year ended on March 31, 2026

			Quarter ended on		Year ended on
No.	Particulars	March 31,	December 31,	March 31,	March 31,	March 31,
		2026	2025	2025	2026	2025
		Unaudited	Unaudited	Unaudited	Audited	Audited
	08. Other comprehensive income
	a) Items that will not be reclassified to profit I loss
	Fair value of equity instruments through other comprehensive income i)	(70.45)	(24.41)	(226.10)	(9.05)	68.39
	ii) Remeasurement gain I (loss) on defined benefit plans	4.02	1.69 <	(2.74)	6.37	(0.91)
	iii) Income tax related to items above	8.86	3.06	32.36	(1.17)	(15.91)
	iv) Shure of other comprehensive income of joint venture company accounted for using the equity method (net of tax)	- 0.01	-	(0.01)	0.01	(0.01)
	b) Items that will be reclassified to profit I loss
	Effective portion of gain I (loss) on cash flow hedges i)	-	0.19	0.76	-	(0.29)
	ii) Exchange differences on translation of foreign operations	10.61	3.60	3.59	--27.07	'/.28
	iii) Income tax related to items above	(3.39)	(0.17)	(0.46)	(4.36)	0.50
	Other comprehensive income, net of tax	(50.34)	(16.04)	(192.60)	18.87	59.05
	Attributable to:
	Owners of the Company	(50.36)	(16.04)	(192.60)	18.85	59.05
	Non-controlling inturests	0.02	-	-	0.02	-
	09. Total comprehensive income for the period	160.78	147.50	(62.47)	708.26	557.88
	Attributable to:
	Owners of the Company	159.79	144.70	(66.10)	696.75	542.98
	Non-controlling interests	0.99	2.80	3.63	11.51	14.90
	10. Paid-up equity share capitol (face value ll' 10 per share)	29.44	29.44	29.44	29.44	29.44
	11. Other equity				6,192.50	5,569.09
	12. Earnings per equity share off 10 each (not annualised, excluding year end)
	Basic earnings (<)	-- 71.38	54.60	42.97	230.25	164.37
	Diluted earnings (<)	71.38	54.60	42.97	230.25	164.37

Part V: Consolidated segment revenue, segment results, segment assets and segment liabilities

			Quarter ended on		Year ended on
No.	Particulars	March 31, 2026	December 31, 2025	March 31, 2025	March 31, 2026	March 31, 2025
		Unaudited	Unaudited	Unaudited	Audited	Audited
	1. Segment revenue (revenue from operations)
	Life Science Chemicals	- 461.74	454.33	443.89	1,805.24	1,691.67
	Performance and Other Chemicals	1.241.30	1,155.39	1,054.72	4,608.73	4,058.24
	Others	19.09	- 18.65	17.14	80.39	73.92
	Sub total	1,722.13	1,628.37	1,515.75	6,494.36	5,823.83
	Less:
	Inter-segment revenue	52.06	54.75	64.11	220.82	240.48
	Total revenue	1,670.07	1,573.62	1,451.64	6,273.54	5,583.35
	2. Segment results
	Life Science Chemicals	143.06	104.66	96.55	417.06	346.76
	Performance and Other Chemicals	124.94	87.89	85.51	416.67	344.85
	Others	1.26	1.76	1.21	11.84	12.30
	Subtotal	269.26	194.31	183.27	845.57	703.91
	Less:
	Finance costs	4.30	3.70	5.42	17.43	23.98
	Other unallocable expenditure (net of unallocable income)	(21.76)	(11.54)	(6.65)	(65.99)	(1.26)
	Add:
	Share of net profit I (loss) of associate and joint venture companies	1.99	1.33	1.59	.37 6	11.30
	Total profit before tax	288.71	203.48	186.09	900.50	692.49
	3. Segment assets
	Life Science Chemicals	,379.25 l	1,318.14	1,323.82	1,379.25"	1,323.82
	Performance and Other Chemicals	3,861.45	3,754.63	3,646.17	3,861.45	3,646.17
	~~\\NS ct & Others	240.92	245.40	222.60	240.92	222.60
	~ <'. c::; " Ct "' .- Unallocable Cf'	- 2,418.87	2,292.27	1,808.40	2,418.87	1,808.40
	g MUMBAl ~ Total assets	7,900.49	7,610.44	7,000.99	7,900.49	7,000.99
4.	f. - Segment liabilities C)
	~ ~ Life Science Chemicals ~tREo rclfl'S'	305.45	282.11	285.31	305.45	285.31
	Performance and Other Chemicals	924.58	835.66	731.42	924.58	731.42
	Others	21.33	23.70	25.26	21.33	25.26
	Unallocable	352.60	333.41	296.63	352.60	296.63
	Total liabilities	1,603.96	1,474.88	1,338.62	1,603.96	1,338.62

('{er)

Port VI: Consolidated Balance Sheet

		As at
		Morch 31,	Morch 31,
No.	Particulars	2026	2025
		Audited	Audited
A	ASSETS
1	Non-current assets
	~ Property, plant and equipment	-- 2,619.44	2,791.98
	Capit~I work-in-progress b)	110.13	124.33
	Investment properties c)	-- - 3.22 --	3.22
	d) Goodwill	29.14	29.14
	Other intangible assets e)	1.46	1.60
	Biological assets other than bearer plants f)	- 22.65	21.40
	g) Investments accounted for using the equity method	56.64	57.10
	Financial assets h)
	Investments i)	887.24	892.58
	Loans ii)	0.34	0.41
	iii) Other financial assets	29.68	17.28
	Income tax assets (net) . i)	-- 5.28	2.63
	Deferred tax assets j)	--- -- 30.79	21.41 -
	Other non-current assets k)	48.88	93.04
	Total non-current assets	3,844~ ~	4,056.12
2	--- Current assets
	a) Inventories	815.47	729.29
	Biological assets other than bearer plants b)	43.07	35.78
	Financial assets c)		--
	Current investments i)	1,647.98	--- 816.27
	ii) Trade receivables	1,271.00	--- -- 1,126.26
	iii) Cash and cash equivalents	85.06	51.37
	Bank balances other than (iii) above	9.61	13.29
	Other financial assets d) Oth~r current assets	23.19 160.22	21.75 150.86
		4,055.60	2,944.87
	Total current assets	7,900.49	7,000.99
	Total assets
B	EQUITY AND LIABILITIES Equity
	Equity share capitol a)	29.46	29.46
	Other equity b)	-- 6,192.50	5,569.09
	Equity attributable to owners of the Company	6,221.96	5,598.55
	Non-controlling interests	74.57	63.82
-	Total equity	-- 6,296.53	5,662.37
	Liabilities
1	Non-current liabilities
	Financial liabilities o)	-- -
	Borrowings i)	160.31	182.01
	Lease liabilities .!!L	- 3.26	4.04
	Other financial liabilities iii) \,SKINS 4 .£	6.20	5.72
	Provisions "«,, b) <\$:	32.04	36.80
	-- g ~ iJlbr Deferred tax liabilities c)	278.27	225.33
	I g -- MUMBAI d) Other non-current liabilities ~1	1.83	0.94
	" Total non-current liabilities	481.91	454.84
2	~ ~ «t ~ent liabilities ~-
	~EJi>fo AC¢~ Financial liabilities o)
	Borrowings i)	19.45	15.68
	ii) Trade payables
	Total outstanding dues of
	a) Micro-enterprises and small enterprises	89.03	38.39 -
	b) Creditors other than micro-enterprises and small enterprises	763.21	--- 576.31
	iii) Other financial liabilities	155.53	179.74
	Contract liabilities b)	41.16	33.16 -
	Other current liabilities c)	15.59	14.23
	Provisions d)	22.99	21.03
	Current tax liabilities (net) e)	15.09	-- 5.24
	Total current liabilities	1,122.05	883.78
	Total liabilities	-- 1,603.96	1,338.62
	Total equity and liabilities	7,900.49	7,000.99

Part VII; Consolidated Statement of Cash Flows

		For the year ended on March 31,	Marc 31,
	Particulars
		202 Audited	2025 Audited
A	CASH FLOW FROM OPERATING ACTIVITIES
	Profit before tax	900.50	692.49
	Adjustments for:
	Depreciation and amortisation expenses	322.13	316.82
	Finance costs	17.44	23.98
	Loss on disposal of property, plant and equipment (net)	1.69	4.85
	Insurance claim		(24.86)
	Unrealised exchange rate difference (net)	(24.70)	5.60
	Effect of exchange rates on translation of operating cash-flows	23.13	6.42
	Bad debts and irrecoverable balances written off	1.30	0.95
	Allowance for doubtful debts I (written back)	(0.63)	3.04
	Dividend income	(20.17)	(7.83)
	Interest income	(19.61)	(7.33)
	-- Changes in fair value of biological assets	(3.01)	(0.45)
	- Liability no longer required written back	(1.36)	(0.86)
	Gain on disposal of current investments measured at FVTPL (net)	(77.31)	(38.69)
	-- -- Income on account of government grants	(15.53)	(0.05)
	Sh are of net profit I (loss) of associate and joint venture companies	(6.37)	(11.30)
	Operating profit before change in operating assets and liabilities	1,097.50	962.77
	Adjustments for:
	(Increase) I Decrease in inventories I biological assets	(91.71)	(114.62)
	(Increase) I Decrease in non-current and current assets	(83.51)	(150.66)
	Increase I (Decrease) in non-current and current liabilities	248.69	56.26
	Cash generated from operating activities	1,170.97	-- 753.75
	Income tax paid (net of refund)	(148.20)	__1±:50.62)
	Net cash flow from operating activities A	1,022.77	603.13
B	CASH FLOW FROM INVESTING ACTIVITIES
	Payments towards property, plant and equipment (including capital advance and CWIP)	(174.87)	(270.18)
	Proceeds from disposal of property, plant and equipment	3.05	-- 1.46
	-- --- Proceeds from insurance claim		22.89
	Proceeds from sale of equity investment measured at FVTOCI	1.23	4.26
	Purchase of equity investment measu~d at FVTOCI	(4.81)	(5.33)
	Purchase of compulsory convertible preference shares measured at FVTOCI	(0.32)
	Purchase of equity instruments of associate company measured at cost	(4.85)	-- (5.00)
	Redemption of bonds I alternate investment fund measured at FVfPL	42.40	62.84
	Repayments of loans given	1.29	1.15
	Disbursements of loans	(0.20)	(0.39)
	Investment in bank deposits (net)	(11.85)	(9.18)
	Purchase of current investments measured at FVTPL (net)	(795.04)	(315.28)
	Interest received	17.58	1.08
	Dividend received	31.84	16.59
	Net cash used in investing activities B	(894.55)	(495.09)
C	CASH FLOW FROM FINANCING ACTIVITIES Repayments of term loans I non-current borrowings	(12.95)	(27.16)

	Repayments of working capital loans I current borrowings	(4.98)	(7.00)
	Repayment of lease liabilities Transaction with non-controlling interests	J!.05) (0.76)	(0.94) (0.13)

	Interest subsidy received	11.88
	Interest paid ~ividend on equity shares	(17.00) (73.60)	(23.67)
	c		(58.8~
	Net cash (used in) I from !i_nancing activities Net increase I (decrease) in cash ~nd cash equivalents	(98.46)	(117.78)
	A+B+C Cash and cash equivalents at the beginning of the year	29.76 51.37	(9.74) 60.26
	Net effect of exchange gain J {!_ass) on cash and cash equivalents held in foreign currencies	3.93	0.85
	Cash and cash equivalents at the end of the year	85.06	51.37

Consolidated financial results for the quarter I year ended on March 31, 2026

Notes:

1. These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time.
1. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on April 23, 2026 and approved by the Board of Directors in its meeting held on April 24, 2026. The Statutory Auditors have expressed an unmodified audit opinion.
1. The Company has reported segment information as per the Ind AS 108, 'Operating Segments', as below:

Name of segment	Main product groups
Life Science Chemicals	Active pharmaceutical ingredients and its intermediates, crop protection chemicals
Performance and Other Chemicals	Adhesion promoters, bulk chemicals, epoxy resins and hardeners, intermediates, textile dyes
Others	Agribiotech, food products, services and others

1. On November 21, 2025, the Government of India notified four Labour Codes, effective immediately, replacing the then existing 29 labour laws. In accordance with Ind AS 19 Employee benefits, changes to employee benefit plans arising from legislative amendments are treated as plan amendments, requiring immediate recognition of changes in the past service cost in the consolidated financial results. This approach is consistent with the guidance issued by the Institute of Chartered Accountants of India. The Group had assessed the impact of these changes and provided an amount of~ 41.25 er and recognised the same for the quarter and nine months ended on December 31, 2025, as employee benefit expenses. Consequent to the employee compensation restructuring and on actuarial valuation, the said liability is now determined at~ 15.84 er. The excess provision of~ 25.41 er has been reversed in the results for the quarter and year ended March 31 2026 as a change in estimate. The Group continues to monitor the finalisation of the Central and State rules and the clarifications that may be issued by the Government on the new labour codes and will recognise the impact of changes in the estimates in that period, as needed.
1. The figures of the last quarter represent the balancing figures between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the respective financial year. There are no material adjustments made in the results for the quarter ended on March 31, 2026, which pertain to earlier periods. These have been subjected to limited review by the Auditors.
1. The Board of Directors has recommended a dividend of~ 30 per share (300%) subject to the approval of the shareholders. "

Mumbai April 24, 2026

S~· (Sunil Lalbhai) (DIN: 00045590) ghairman and Managing Director

Atul Ltd

Atul House, GI Patel Marg, Ahmedabad 380 014, Gujarat, India [email protected] I www.atul.co.in (+91 79) 26461294 I 3706 CIN:L99999Gj1975PLC002859

Extract of financial results for the quarter I year ended on March 31, 2026

[in terms of Regulation 47(l)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015]

				Standalone			<"er) Consolidated
		for the quarter ended on		for the year ended on		for the quarter ended on				for the year ended on
No.	Particulars	March 31, 2026 Unaudited	December 31, 2025 Unaudited	March 31, 2025 Unaudited	March 31, 2026	March 31, 2025 Audited	March 31, 2026	December 31, 2025 Unaudited	March 31, 2025 Unaudited	March 31, 2026 Audited	March 31, 2025 Audited
	1. Total income from operations	1.497.93	1,351.56	1.314.79	Audited 5,563.57	-- 5,074.69	Unaudited I 1.670.07	1,573.62	1.451.64	6,273.54	5,583.35
	- 2. Net profit for the period before tax	248.74	-- 154.88	165.49	759.97	623.33	288.71	- 203.48	---- --- 186.09	-- 900.50	692.49
	3. Net profit for the period after tax	-- 203.84	-- 121.15	125.69	595.04	- - 456.28	211.12	163.54	130.13	689.39	498.83
	4. Total comprehensive income for the period [comprising profit for the period (after tax) and other comprehensive income (after tax)]	146.97	101.51	- (69.40)	591.13	- 507.48	---- 160.78	147.50	(62.47)	- ~ 708.26	557.88
	5. Equity share capital	- 29.44	- 29.44	,______ 29.44	-- 29.44	29.44	29.44	29.44	29.44	29.44	29.44
	6. Other equity	- -			6,026.46	f--- 5,508.65		-		~ ~ 6,192.50	5,569.09
	7. Earnings per equity share of" 10 each (not annualised, excluding year end)
	Basic earnings ('J	69.24	41.15	42.69	-- 202.11	154.98	71.38	54.60	42.97	230.25	164.3'7
	Diluted earnings ('J	69.24	41.15	42.69	202.11	154.98	71.38	- 54.60	42.97	230.25	164.37

Note

The above is an extract of the detailed format of results filed with the stock exchanges under Regulation 33 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015. The details in prescribed format of the results are available on the websites of the stock exchanges (www.bseindia.com, www.nseindia.com) and the Company (www.atul.co.in).

For Atul Ltd

S~· (Sunil La lbha i) (DIN: 00045590)

Chairman and Managing Director

Mumbai April24,2026

Chartered Accountants One International Center, Tower 3, 31st Floor, Senapati Bapat Marg Elphinstone Road (West) Mumbai-400 013 Maharashtra, India

Tel: +91226185 6000 Fax: +91226185 4101

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL STANDALONE FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF ATUL LIMITED

Opinion and Conclusion

We have (a) audited the Standalone Financial Results for the year ended March 31, 2026 and (b) reviewed the Standalone Financial Results for the quarter ended March 31, 2026 (refer 'Other Matters' section below), which were subject to limited review by us, both included in the accompanying "Statement of Standalone Financial Results for the Quarter and Year Ended March 31, 2026 of ATUL LIMITED (the "Company"), (the "Statement"), being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "LODR Regulations").

(a) Opinion on Annual Standalone Financial Results

In our opinion and to the best of our information and according to the explanations given to us the Standalone Financial Results for the year ended March 31, 2026:

i. are presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended; and
ii. give a true and fair view in conformity with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India of the net profit and other comprehensive income and other financial information of the Company for the year then ended.

(b) Conclusion on Unaudited Standalone Financial Results for the quarter ended March 31, 2026

With respect to the Standalone Financial Results for the quarter ended March 31, 2026, based on our review conducted as stated in paragraph (b) of Auditor's Responsibilities section below, nothing has come to our attention that causes us to believe that the Standalone Financial Results for the quarter ended March 31, 2026, prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement.

Regd. Office: One International Center, Tower 3, 31st floor, Senapati Bapat Marg, Elphinstone Road (West), Mumbai-400 013, Maharashtra, India. Deloitte Haskins & Sells LLP is registered with Limited Liability having LLP identif!cation No: AAB-8737

Basis for Opinion on the Audited Standalone Financial Results for the year ended March 31, 2026

We conducted our audit in accordance with the Standards on Auditing ("SA"s) specified under Section 143(10) of the Companies Act, 2013 (the "Act"). Our responsibilities under those Standards are further described in paragraph (a) of Auditor's Responsibilities section below. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India (the "ICAI") together with the ethical requirements that are relevant to our audit of the Standalone Financial Results for the year ended March 31, 2026 under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our audit opinion.

Management's and Board of Directors' Responsibilities for the Statement

This Statement which includes the Standalone Financial Results is the responsibility of the Company's Board of Directors and has been approved by them for the issuance. The Standalone Financial Results for the year ended March 31, 2026 has been compiled from the related audited standalone financial statements. This responsibility includes the preparation and presentation of the Standalone Financial Results for the quarter and year ended March 31, 2026 that give a true and fair view of the net profit and other comprehensive income and other financial information in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the LODR Regulations. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Standalone Financial Results that give a true and fair view and is free from material misstatement, whether due to fraud or error.

In preparing the Standalone Financial Results, the Board of Directors is responsible for assessing the Company's ability, to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors is also responsible for overseeing the financial reporting process of the Company.

Auditor's Responsibilities

{a) Audit of the Standalone Financial Results for the year ended March 31, 2026

Our objectives are to obtain reasonable assurance about whether the Standalone Financial Results for the year ended March 31, 2026 as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud

or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of this Standalone Financial Results.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the Annual Standalone Financial Results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates made by the Board of Directors.
Evaluate the appropriateness and reasonableness of disclosures made by the Board of Directors in terms of the requirements specified under Regulation 33 of the LODR Regulations.
Conclude on the appropriateness of the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Company to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the Statement or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the Annual Standalone Financial Results, including the disclosures, and whether the Annual Standalone Financial Results represent the underlying transactions and events in a manner that achieves fair presentation.
Obtain sufficient appropriate audit evidence regarding the Annual Standalone Financial Results of the Company to express an opinion on the Annual Standalone Financial Results.

Materiality is the magnitude of misstatements in the Annual Standalone Financial Results that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the Annual Standalone Financial Results may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the Annual Standalone Financial Results.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

(b) Review of the Standalone Financial Results for the quarter ended March 31, 2026

We conducted our review of the Standalone Financial Results for the quarter ended March 31, 2026 in accordance with the Standard on Review Engagements ("SRE") 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the !CAI. A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with SAs specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Other Matters

• The Statement includes the results for the Quarter ended March 31, 2026 being the balancing figure between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the current financial year which were subject to limited review by us. Our report on the Statement is not modified in respect of this matter.

For DELOITTE HASKINS & SELLS LLP

Chartered Accountants (Firm's Registration No. 117366W/W-100018)

~ ' \

Ketan Vora Partner (Membership No . 100459) (UDIN: 2-6i OO't5~ X g{'1K~J" il't.1.

Place: Mumbai Date: April 24, 2026

Chartered Accountants One International Center, Tower 3, 31st Floor, Senapati Bapat Marg Elphinstone Road (West) Mumbai - 400 013 Maharashtra, India

Tel: +91226185 6000 Fax:+912261854101

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL CONSOLIDATED FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS